tradingkey.logo
tradingkey.logo
Search

Aethlon Medical Inc

AEMD
Add to Watchlist
2.100USD
-0.040-1.87%
Close 05/15, 16:00ETQuotes delayed by 15 min
3.30MMarket Cap
LossP/E TTM

Aethlon Medical Inc

2.100
-0.040-1.87%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Aethlon Medical Inc

Currency: USD Updated: 2026-05-15

Key Insights

Aethlon Medical Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 11.50.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Aethlon Medical Inc's Score

Industry at a Glance

Industry Ranking
133 / 206
Overall Ranking
311 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Aethlon Medical Inc Highlights

StrengthsRisks
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Fairly Valued
The company’s latest PE is -0.04, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 101.87K shares, increasing 29.66% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.

Analyst Rating

Based on 2 analysts
Hold
Current Rating
11.500
Target Price
+437.38%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Aethlon Medical Inc is 6.83, ranking 108 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score
6.83
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.67

Operational Efficiency

2.77

Growth Potential

6.78

Shareholder Returns

6.92

Aethlon Medical Inc's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Aethlon Medical Inc is 7.19, ranking 114 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.04, which is -88.94% below the recent high of -0.00 and -199.77% above the recent low of -0.13.

Score

Industry at a Glance

Previous score
7.19
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 133/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

The current earnings forecast score of Aethlon Medical Inc is 6.00, ranking 175 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 12.38, with a high of 15.00 and a low of 9.75.

Score

Industry at a Glance

Previous score
6.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts
Hold
Current Rating
11.500
Target Price
+437.38%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Aethlon Medical Inc
AEMD
2
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
35
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Aethlon Medical Inc is 5.84, ranking 168 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 2.36 and the support level at 1.97, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
5.81
Change
0.03

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.050
Neutral
RSI(14)
40.262
Neutral
STOCH(KDJ)(9,3,3)
3.585
Oversold
ATR(14)
0.121
High Vlolatility
CCI(14)
-96.776
Neutral
Williams %R
100.000
Oversold
TRIX(12,20)
0.008
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
2.152
Sell
MA10
2.245
Sell
MA20
2.245
Sell
MA50
2.168
Sell
MA100
2.287
Sell
MA200
4.903
Sell

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Aethlon Medical Inc is 3.00, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 6.49%, representing a quarter-over-quarter increase of 16.62%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Armistice Capital LLC
84.50K
--
Rossetti (Angela)
1.96K
+215.78%
Broenniman (Edward G)
1.65K
+643.24%
Gikakis (Nicolas)
1.38K
+673.03%
Shah (Chetan S)
1.38K
+3944.12%
Alumni Capital LP
22.56K
--
Ikarian Capital LLC
14.36K
-6.52%
Intracoastal Capital, L.L.C.
2.10K
--
Morgan Stanley Smith Barney LLC
2.05K
+204600.00%
1
2

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Aethlon Medical Inc is 1.50, ranking 186 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.50. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
1.50
Change
0
Beta vs S&P 500 index
1.49
VaR
+9.32%
240-Day Maximum Drawdown
+94.35%
240-Day Volatility
+140.62%

Return

Best Daily Return
60 days
+12.72%
120 days
+14.87%
5 years
+97.30%
Worst Daily Return
60 days
-6.97%
120 days
-23.49%
5 years
-53.10%
Sharpe Ratio
60 days
+0.32
120 days
-0.98
5 years
-0.67

Risk Assessment

Maximum Drawdown
240 days
+94.35%
3 years
+94.56%
5 years
+99.53%
Return-to-Drawdown Ratio
240 days
-0.98
3 years
-0.14
5 years
-0.19
Skewness
240 days
+3.49
3 years
+2.93
5 years
+2.82

Volatility

Realised Volatility
240 days
+140.62%
5 years
+244.51%
Standardised True Range
240 days
+39.17%
5 years
+35.08%
Downside Risk-Adjusted Return
120 days
-150.78%
240 days
-150.78%
Maximum Daily Upside Volatility
60 days
+65.64%
Maximum Daily Downside Volatility
60 days
+48.10%

Liquidity

Average Turnover Rate
60 days
+1.76%
120 days
+3.23%
5 years
--
Turnover Deviation
20 days
-95.78%
60 days
-95.07%
120 days
-90.95%

Peer Comparison

Healthcare Equipment & Supplies
Aethlon Medical Inc
Aethlon Medical Inc
AEMD
5.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI